Diabetes patients taking glitazone antidiabetes drugs had a 28 percent lower incidence of Parkinson’s disease than people taking other antidiabetic treatments, according to new research led by the London School of Hygiene & Tropical Medicine.
Diabetes patients taking glitazone antidiabetes drugs had a 28 percent lower incidence of Parkinson’s disease than people taking other antidiabetic treatments, according to new research led by the London School of Hygiene & Tropical Medicine.